Emily Wheeler is Vice President of Infectious Disease Policy at the Biotechnology Innovation Organization (BIO). Ms. Wheeler leads the association’s policy efforts to stimulate innovation and access for new and existing vaccines, medical countermeasures, therapeutics to address antimicrobial resistance, and to promote greater development and utilization of new technologies for the prevention and treatment of infectious diseases. She is also the Director of the Working to Fight AMR public awareness campaign. Ms. Wheeler serves on the Presidential Advisory Council on Combating Antibiotic-Resistant Bacteria (PACCARB) and is a member of the Stakeholder Group for the Global AMR R&D Hub. She represents the biotechnology sector as a Board Member of the INTREPID Alliance and the AMR Industry Alliance (AMRIA) and is co-Chair of AMRIA’s Research and Science Working Group. Ms. Wheeler has experience in health care policy and provision both domestically and internationally through fieldwork in Senegal and Rwanda focused on maternal and child health, nutrition, emergency relief for refugee populations, and monitoring and evaluation for a variety of programs. Ms. Wheeler is a Presidential Academic Scholar from George Washington University and earned a bachelor’s degree in International Affairs with dual concentrations in Global Public Health and International Development.